PIERIAN BIOSCIENCES LIMITED

Active London

Other professional, scientific and technical activities n.e.c.

6 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
P

PIERIAN BIOSCIENCES LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 4 Aug 2015 Active London, United Kingdom 6 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.

Previous Company Names

DIATECH ONCOLOGY LIMITED 4 Aug 2015 — 7 Mar 2022
Accounts Submitted 17 Sept 2025 Next due 25 Sept 2026 3 months remaining
Confirmation Submitted 5 Mar 2026 Next due 14 Jan 2027 7 months remaining
Net assets £-3M £1M 2024 year on year
Total assets £813K £178K 2024 year on year
Total Liabilities £4M £837K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

101 New Cavendish Street 1st Floor South London W1W 6XH United Kingdom

Website

www.example.com

Full company profile for PIERIAN BIOSCIENCES LIMITED (09716938), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 4 Aug 2015. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 25 Dec 2025
Due by 25 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£16.20k

Decreased by £31.24k (-66%)

Net Assets

-£2.77M

Decreased by £1.02M (-58%)

Total Liabilities

£3.58M

Increased by £837.43k (+31%)

Turnover

N/A

Employees

6

Increased by 1 (+20%)

Debt Ratio

440%

Increased by 163 (+59%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 4Oct 2019Series B
Investor 5Oct 2019Series B
Investor 6Oct 2019Series B

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 2,676,600 Shares £2.48m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Dec 202420,000£20k£1
3 Dec 202420,000£20k£1
29 Nov 202440,000£40k£1
29 Nov 202440,000£40k£1
26 Aug 2024100,000£100k£1

Officers

Officers

2 active 1 resigned
Status
Cohen, Laurence JohnDirectorBritishEngland7410 Nov 2015Active
Miller Jr, Andrew WoodfinDirectorAmericanUnited States624 Aug 2015Active

Shareholders

Shareholders (43)

The Chimneys Investment Company Limiteds
11.6%
670,000
The Chimneys Investment Company Limited
11.6%
670,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Pierian Holdings, Inc.

United States Of America

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

PIERIAN BIOSCIENCES LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Mar 2026Confirmation StatementConfirmation statement made on 31 Dec 2025 with updates
2 Mar 2026OfficersChange to director Mr Andrew Woodfin Miller Jr on 31 Dec 2025
17 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
27 Jan 2025Confirmation StatementConfirmation statement made on 31 Dec 2024 with updates
17 Jan 2025CapitalAllotment of shares (GBP 6.7268) on 30 May 2024
5 Mar 2026 Confirmation Statement

Confirmation statement made on 31 Dec 2025 with updates

2 Mar 2026 Officers

Change to director Mr Andrew Woodfin Miller Jr on 31 Dec 2025

17 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

27 Jan 2025 Confirmation Statement

Confirmation statement made on 31 Dec 2024 with updates

17 Jan 2025 Capital

Allotment of shares (GBP 6.7268) on 30 May 2024

Recent Activity

Latest Activity

Confirmation statement made on 31 Dec 2025 with updates

2 months ago on 5 Mar 2026

Change to director Mr Andrew Woodfin Miller Jr on 31 Dec 2025

2 months ago on 2 Mar 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 17 Sept 2025

Confirmation statement made on 31 Dec 2024 with updates

1 years ago on 27 Jan 2025

Allotment of shares (GBP 6.7268) on 30 May 2024

1 years ago on 17 Jan 2025